Searchable abstracts of presentations at key conferences in endocrinology

ea0081p167 | Pituitary and Neuroendocrinology | ECE2022

Patient-reported outcomes (PRO) in adult growth hormone deficiency (aghd) for an improved patients’ management: results from the management of AGHD(MAGHD) study

Monzani Maria Laura , Pederzoli Simone , Bellelli Alessio , Magnani Elisa , Diazzi Chiara , Golinelli Caterina , Pacchioni Marco , Orsini Mirko , Rochira Vincenzo

Background: AGHD is a recognized clinical entity, but symptoms are quite nonspecific; the lack of objective tools able to measure patientsÂ’ health status remains the main barrier in clinical monitoring and treatment.Aim: The MAGHD Study aims improving AGHD patientsÂ’ management through a Smartphone app (MAGHDApp) and a fit-watch integrated with a software framework able to merge daily data of patientsÂ’ well-being and physical activity with ...

ea0090p687 | Pituitary and Neuroendocrinology | ECE2023

Smartphone App on Follow-up of Adult Growth Hormone Deficiency (AGHD) Patients: Results From the Management of AGHD (MAGHD) Study

Bellelli Alessio , Golinelli Caterina , Laura Monzani Maria , Pederzoli Simone , Magnani Elisa , Beltrami Elisa , Pacchioni Marco , Orsini Mirko , Diazzi Chiara , De Vincentis Sara , Rochira Vincenzo

Background: AGHD significantly impacts on metabolism, body composition and quality of life (QoL), including sexuality.AIM: To investigate the impact of a smartphone App on AGHD monitoring, especially QoL and comorbidities as well as on both body composition and biochemical parameters.Methodology: 83 AGHD patients were enrolled in this prospective, open-label, monocentric study (MAGHD Study) of 24-month duration. Patients were evalu...

ea0099ep1249 | Late Breaking | ECE2024

Prevalence and characterization of sexual dysfunctions in male patients with hyperprolactinemia in a national registry

De Fraia Antonio , Maseroli Elisa , Sbardella Emilia , de Angelis Cristina , Minnetti Marianna , Simone Auriemma Renata , Indirli Rita , Golinelli Caterina , Cignarelli Angelo , Vignozzi Linda , Corona Giovanni , Isidori Andrea , Pivonello Rosario

Hyperprolactinemia is frequently accompanied by sexual dysfunctions, represented by decreased libido, erectile dysfunction and ejaculatory disorders. Moreover, cabergoline (CAB), used for treatment of hyperprolactinemia, is known to influence sexual function. Aim of the study was to evaluate sexual function in males with hyperprolactinemia under medical therapy. Data were retrieved from GONADIS, a national registry on gonadal status and reproductive and psycho-sexual function ...